Friday , October 20 2017
Home / KEEP BUT DO NOT DISPLAY / Alerts / FDA Approves Synjardy

FDA Approves Synjardy

Empagliflozin/metformin is new combo medication for type 2 diabetes. More information coming in next week’s newsletter.